Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance

Autor: Global PETTS Investigators, Cegielski, J. Peter, Kurbatova, Ekaterina, van der Walt, Martie, Brand, Jeannette, Ershova, Julia, Tupasi, Thelma, Caoili, Janice Campos, Dalton, Tracy, Contreras, Carmen, Yagui, Martin, Bayona, Jaime, Kvasnovsky, Charlotte, Leimane, Vaira, Kuksa, Liga, Chen, Michael P., Via, Laura E., Hwang, Soo Hee, Wolfgang, Melanie, Volchenkov, Grigory V., Somova, Tatiana, Smith, Sarah E., Akksilp, Somsak, Wattanaamornkiet, Wanpen, Kim, Hee Jin, Kim, Chang-ki, Kazennyy, Boris Y., Khorosheva, Tatiana, Kliiman, Kai, Viiklepp, Piret, Jou, Ruwen, Huang, Angela Song-En, Vasilyeva, Irina A., Demikhova, Olga V.

Publikováno v: Clinical Infectious Diseases, 2016 Feb . 62(4), 418-430.

Externí odkaz: https://www.jstor.org/stable/26370244

Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia.

Autor: Ershova, Julia V., Volchenkov, Grigory V., Somova, Tatiana R., Kuznetsova, Tatiana A., Kaunetis, Natalia V., Kaminski, Dorothy, Demikhova, Olga V., Chernousova, Larisa N., Vasilyeva, Irina A., Kerr, Eleanor M., Cegielski, J. Peter, Kurbatova, Ekaterina V.

Publikováno v: BMC Infectious Diseases; 7/25/2020, Vol. 20 Issue 1, p1-9, 9p, 2 Diagrams, 4 Charts, 1 Graph

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study.

Autor: Dalton T; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. tldalton@cdc.gov, Cegielski P, Akksilp S, Asencios L, Campos Caoili J, Cho SN, Erokhin VV, Ershova J, Gler MT, Kazennyy BY, Kim HJ, Kliiman K, Kurbatova E, Kvasnovsky C, Leimane V, van der Walt M, Via LE, Volchenkov GV, Yagui MA, Kang H, Akksilp R, Sitti W, Wattanaamornkiet W, Andreevskaya SN, Chernousova LN, Demikhova OV, Larionova EE, Smirnova TG, Vasilieva IA, Vorobyeva AV, Barry CE 3rd, Cai Y, Shamputa IC, Bayona J, Contreras C, Bonilla C, Jave O, Brand J, Lancaster J, Odendaal R, Chen MP, Diem L, Metchock B, Tan K, Taylor A, Wolfgang M, Cho E, Eum SY, Kwak HK, Lee J, Lee J, Min S, Degtyareva I, Nemtsova ES, Khorosheva T, Kyryanova EV, Egos G, Perez MT, Tupasi T, Hwang SH, Kim CK, Kim SY, Lee HJ, Kuksa L, Norvaisha I, Skenders G, Sture I, Kummik T, Kuznetsova T, Somova T, Levina K, Pariona G, Yale G, Suarez C, Valencia E, Viiklepp P

Publikováno v: Lancet (London, England) [Lancet] 2012 Oct 20; Vol. 380 (9851), pp. 1406-17. Date of Electronic Publication: 2012 Aug 30.